Krysha Lee, a third-year occupational therapy student, is breaking new ground with a capstone project that blends occupational therapy and apparel design.

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...

The program taps into several OpenAI models and can be used across a wide range of therapeutic indications. Both Big Pharma ...

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

Ultragenyx Pharmaceutical (RARE) shows promising results for GTX-102 in Angelman syndrome Phase 1/2 trial, supporting a Phase ...

From masthead additions at design publications to a flurry of C-suite appointments, read on for BOH’s monthly roundup of ...

Acrivon Therapeutics, Inc. ("Acrivon” or "Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company ...

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...

RBC Capital analyst Leonid Timashev maintained a Hold rating on Design Therapeutics (DSGN – Research Report) yesterday and set a price ...

And thirdly, as a maintenance therapy following cessation of GLP-1s to prevent rebound ... our focus is now on the ...

Absci Corporation (ABSI) and Twist Bioscience Corporation (TWST) unveiled a collaboration to design a novel therapeutic using generative AI.

The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...